Clinical Trials, Filler and Protein - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Trials

Filler

Protein

Bone Void Filler Cerament G: The Combination Product by BONESUPPORT Gets Market Authorization from the FDA

XTalks

MAY 25, 2022

Ceramanet G, a bone void filler with the antibiotic gentamicin, fills bone voids and immediately begins bone healing with protection. Cerament G is a bone void filler treatment that can fill the gaps in the affected bones and simultaneously deliver the antibiotic gentamicin to reduce the risk of reinfection. mg/mL of cerament paste.

Filler

Filler Production Marketing Sales

TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis PainOn-schedule completion of enrollment despite COVID-19 pandemic; unique trial design evaluates safety and efficacy of single & repeat doses

The Pharma Data

DECEMBER 27, 2020

We remain confident that results from this trial will be positive given the outstanding results observed in our Phase II clinical trial.”. Current intraarticular anti-inflammatory treatments for OA have potentially toxic side effects and may lead to the destruction of cartilage filler proteins.

Trials

Trials Clinical Trials Clinical Trials Containment

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Bone Void Filler Cerament G: The Combination Product by BONESUPPORT Gets Market Authorization from the FDA

TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis PainOn-schedule completion of enrollment despite COVID-19 pandemic; unique trial design evaluates safety and efficacy of single & repeat doses

Webinars

Stay Connected